Wai Conrad's Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Sep 17, 2024
- Accession no.
- 0001801170-24-000192
- Filed
- Sep 17, 2024
- Trade date
- Sep 13-14, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001801170-25-000170 (Jul 10, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wai ConradCIK 0001971702 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Class A Common Stock | AGrant or awardAcquired | +189,934 | $0.00 | $0 | 3,043,529 | Direct | |
| Sep 13, 2024 | Class A Common Stock | FTax withholdingDisposed | −93,180 | $2.99 | −$278,608.2 | 2,950,349 | Direct | |
| Sep 14, 2024 | Class A Common Stock | FTax withholdingDisposed | −98,217 | $2.99 | −$293,668.83 | 2,852,132 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.